Contrasting Wellness Center USA (OTCMKTS:WCUI) and Innovus Pharmaceuticals (OTCMKTS:INNV)

Innovus Pharmaceuticals (OTCMKTS:INNV) and Wellness Center USA (OTCMKTS:WCUI) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations and dividends.

Profitability

This table compares Innovus Pharmaceuticals and Wellness Center USA’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Innovus Pharmaceuticals -34.02% -1,053.29% -82.10%
Wellness Center USA -2,225.88% N/A -4,699.78%

Earnings & Valuation

This table compares Innovus Pharmaceuticals and Wellness Center USA’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Innovus Pharmaceuticals $23.99 million 0.18 -$8.28 million ($4.16) -0.41
Wellness Center USA $210,000.00 24.57 -$3.40 million N/A N/A

Wellness Center USA has lower revenue, but higher earnings than Innovus Pharmaceuticals.

Institutional and Insider Ownership

0.2% of Innovus Pharmaceuticals shares are owned by institutional investors. 12.8% of Innovus Pharmaceuticals shares are owned by company insiders. Comparatively, 9.3% of Wellness Center USA shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Volatility & Risk

Innovus Pharmaceuticals has a beta of 2.24, suggesting that its share price is 124% more volatile than the S&P 500. Comparatively, Wellness Center USA has a beta of 2.68, suggesting that its share price is 168% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Innovus Pharmaceuticals and Wellness Center USA, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Innovus Pharmaceuticals 0 0 1 0 3.00
Wellness Center USA 0 0 0 0 N/A

Summary

Innovus Pharmaceuticals beats Wellness Center USA on 6 of the 10 factors compared between the two stocks.

About Innovus Pharmaceuticals

Innovus Pharmaceuticals, Inc., a pharmaceutical company, engages in the development, licensing, and commercialization of non-prescription medicines and consumer care products in the United States. Its products include Zestra, a proprietary blend of essential oils to enhance desire, arousal, and satisfaction in women; EjectDelay, an over-the-counter monograph compliant benzocaine gel for premature ejaculation; Sensum+, a non-medicated cream for penile sensitivity; Zestra Glide, a water-based longer lasting lubricant; Vesele, a proprietary oral supplement for promoting sexual health; and Androferti, a natural supplement to support male reproductive health and sperm quality. The company also offers Beyond Human testosterone booster, ketones, krill oil, omega 3 fish oil, Vision Formula, blood sugar, colon cleanse, green coffee extract, and growth agent; RecalMax for brain health; UriVarx, a supplement for overactive bladder and urinary incontinence; PEVarx, a supplement for peak sexual performance; ProstaGorx, a supplement for prostate support; and FlutiCare, a nasal spray. In addition, its products include Apeaz for pain relief; AllerVarx for allergy relief; ArthriVarx for joint pain; Xyralid, a hemorrhoid cream; Can-C eye drop and eye care capsule; MZS, a melatonin formula to enhance sleep patterns; and Diabasens, a diabetic foot cream. The company's pipeline products comprise UriVarx for urinary tract infection; Xyralid suppositories for hemorrhoidal symptoms; GlucoGorx supplement, glucometer, lancing device, and GlucoGorx strip for blood sugar levels; Vesele and RecalMax nitric oxide strips. It markets and sells its products through commercial partners to primary care physicians, urologists, gynecologists, and therapists, as well as to other healthcare providers; and directly to consumers through online channels, retailers, and wholesalers. Innovus Pharmaceuticals, Inc. was founded in 2008 and is headquartered in San Diego, California.

About Wellness Center USA

Wellness Center USA, Inc. engages in the healthcare and medical businesses in the United States and internationally. It operates through two segments, Medical Devices; and Authentication and Encryption Products and Services. The company is primarily involved in the marketing and distribution of online sports and nutrition supplements. It also designs, develops, manufactures, markets, and distributes targeted ultraviolet phototherapy devices, including Psoria-Light that is used in targeted PUVA photochemistry and UVB phototherapy for the treatment of skin conditions, such as psoriasis, vitiligo, atopic dermatitis, seborrheic dermatitis, and leukoderma. In addition, the company offers tradenames and marks, and related encryption and authentication solutions, which provide product security technologies within the security and supply chain management vertical sectors; and offers data intelligence services comprising proprietary, unprecedented, and actionable technology for industries, companies, and agencies. Wellness Center USA, Inc. was founded in 2010 and is based in Hoffman Estates, Illinois.

Receive News & Ratings for Innovus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.